Figure 6.

Further exploration of MAS1L, TCP10L2, and CRHR2. Notes: (a–c) the expression level of MAS1L, TCP10L2, and CRHR2 in normal and tumor tissue; (d–f) disease-specific survival of MAS1L, TCP10L2, and CRHR2; (g–i) progression-free survival of MAS1L, TCP10L2, and CRHR2.